PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Refresh Agency

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

VivaPrime Receives Certification for Good Manufacturing Practices  - VivaPrime receives GMP Certification (Good Manufacturing Practices) by NSF -
VivaPrime Receives Certification for Good Manufacturing Practices


NewswireToday - /newswire/ - Boulder, CO, United States, 2010/07/06 - VivaPrime receives GMP Certification (Good Manufacturing Practices) by NSF -

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


VivaPrime, a line of holistic nutritional lifestyle supplements that recently launched in the US market, receives the Good Manufacturing Practices (GMP) certification for its dietary supplements from NSF International.

The NSF International GMP Certification ensures that manufacturing processes fully comply with the international guidelines on food supplements. Rigorous testing of VivaPrime’s condition specific dietary supplements includes: label and formulation review, GMP plant audits and product testing and safety evaluation. The certification qualifies VivaPrime as a sound manufacturer of dietary supplements ensuring that VivaPrime holistic lifestyle supplement products do not contain unwarranted, toxic or banned substances including but not limited to heavy metals, pesticides, preservatives, artificial colors or flavors.

“As a member of the natural products industry, VivaPrime is committed to providing the highest quality and safety of the products we manufacture. We have invested over $25 million in building a state-of-the-art manufacturing facility with in-house quality testing and R&D capabilities. The NSF International certification will instill additional confidence in our customers.” said Akshay Mehta, CEO of VivaPrime.

All of VivaPrime’s 11 wellness and condition-specific supplement products meet the highest quality standards. The company continues to move forward with additional third party certifications to surpass the highest quality benchmarks and demonstrate to consumers and stake holders that VivaPrime not only practices responsible manufacturing, but is dedicated to providing the best products available on the market.

About NSF International

NSF International, an independent, not-for-profit organization, certifies products and writes standards for food, water and consumer goods to minimize adverse health effects and protect the environment ( Founded in 1944, NSF is committed to protecting public health and safety worldwide. NSF is a World Health Organization Collaborating Centre for Food and Water Safety and Indoor Environment.

About VivaPrime

VivaPrime ( holistic nutritional solutions are designed to target specific health concerns, while improving overall health and wellness. The products combine the best of nature with quality science, and are designed with optimum dosages to provide comprehensive, convenient and cost effective solutions. Every VivaPrime product is blister packed to protect the potency of natural ingredients from oxidation and humidity.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Written by / Agency / Source: Refresh Agency


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick Newswire Today Visibility Checker


Distribution / Indexing: [+]

# # #

  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!

VivaPrime Receives Certification for Good Manufacturing Practices

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Publisher Contact: Sandja Brugmann - 
248-640-5484 adriane[.]
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Refresh Agency securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Articles From Refresh Agency / Company Profile

Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application
Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy
Greenphire Continues Commitment to Clinical Research Site Sustainability and Innovation at Global Site Solutions Summit
Frost & Sullivan Highlights argenx for Enhancing the Therapeutic Qualities of Human Antibodies with its Proprietary Antibody Discovery Platform, SIMPL
FDA Grants Breakthrough Therapy Designation for Genentech’s Actemra® (Tocilizumab) in Giant Cell Arteritis, a Form of Vasculitis
MDxHealth Announces Agreement with SouthGenetics for Distribution of SelectMDx in Central/South America
BD and Apax Partners Announce Closing of Joint Venture to Launch Global Respiratory Business
Exosome Diagnostics Enters Agreement with Amgen
Sartorius Stedim Biotech Launches Two Single-use Sartocon® Loop Assemblies with Integrated Polyethersulfone (PESU) Membrane
BD Expands Efforts to Combat Antimicrobial Resistance with New Automated ID/AST System

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business



Visit  Intrinsic Executive Search Ltd

  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (